E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 2/5/2024 in the Prospect News Structured Products Daily.

New Issue: RBC prices $750,000 barrier enhanced return notes linked to Eli Lilly

By Kiku Steinfeld

Chicago, Feb. 5 – Royal Bank of Canada priced $750,000 of 0% barrier enhanced return notes due Dec. 19, 2024 linked to the stock of Eli Lilly and Co., according to a 424B2 filing with the Securities and Exchange Commission.

If the stock return is positive, the payout at maturity will be par plus twice the gain, capped at 128.05%.

Investors will receive par if the stock declines by 20% or less and will lose 1% for every 1% that the stock declines from initial level.

RBC Capital Markets, LLC is the agent.

Issuer:Royal Bank of Canada
Issue:Barrier enhanced return notes
Underlying stock:Eli Lilly and Co.
Amount:$750,000
Maturity:Dec. 19, 2024
Coupon:0%
Price:Par
Payout at maturity:Par plus twice any gain, capped at 128.05%; par if stock declines by 20% or less; otherwise, 1% loss for every 1% that the stock declines from initial level
Initial levels:$447.71
Barrier levels:$358.17; 80% of initial levels
Pricing date:June 20, 2023
Settlement date:June 23, 2023
Agent:RBC Capital Markets, LLC
Fees:2.25%
Cusip:78016NJA6

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.